Norepinephrine vs. Phenylephrine in Septic Shock Patients with Tachycardia

Current Guidelines for Vasopressor Selection

• The Society of Critical Care Medicine recommends norepinephrine as the first-choice vasopressor for septic shock (strong recommendation, moderate quality evidence) 1, 2, 3
• The target mean arterial pressure (MAP) is 65 mmHg initially 2

Specific Recommendations Regarding Phenylephrine

• Phenylephrine is not recommended in septic shock except in specific circumstances, such as when norepinephrine is associated with serious arrhythmias 1, 2
• Phenylephrine may be considered when cardiac output is known to be high and blood pressure persistently low 1, 2
• Phenylephrine can be used as salvage therapy when combined inotrope/vasopressor drugs and low-dose vasopressin have failed to achieve MAP target 1, 2

Rationale for Norepinephrine Preference

• Norepinephrine increases MAP primarily through vasoconstriction while causing less increase in heart rate compared to other vasopressors like dopamine 4

Management Algorithm for Septic Shock with Tachycardia

• The initial vasopressor choice is norepinephrine, with a target MAP of at least 65 mmHg 1, 2, 3
• If additional vasopressor support is needed, vasopressin or epinephrine can be added 1, 2

Practical Implementation

• An arterial catheter should be placed as soon as practical in all patients requiring vasopressors 1, 2
• Adequate fluid resuscitation should be ensured before or concurrent with vasopressor initiation 4
• Vasopressors should be titrated to target MAP while monitoring for signs of adequate perfusion (lactate levels, urine output, mental status) 4